Works matching IS 14611457 AND DT 2017 AND VI 20 AND IP 8

Results: 9

Phase II Proof-of-Concept Trial of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Major Depressive Disorder.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 613, doi. 10.1093/ijnp/pyx033

By:

Connor, Kathryn M.;
Ceesay, Paulette;
Hutzelmann, Jill;
Snavely, Duane;
Krystal, Andrew D.;
Trivedi, Madhukar H.;
Thase, Michael;
Lines, Christopher;
Herring, W. Joseph;
Michelson, David

Publication type:

Article

CORRIGENDUM.

Published in:: 2017
Publication type:: Correction Notice

Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 619, doi. 10.1093/ijnp/pyx034

By:

Fiori, Laura M.;
Lopez, Juan Pablo;
Richard-Devantoy, Stéphane;
Berlim, Marcelo;
Chachamovich, Eduardo;
Jollant, Fabrice;
Foster, Jane;
Rotzinger, Susan;
Kennedy, Sidney H.;
Turecki, Gustavo

Publication type:

Article

Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 660, doi. 10.1093/ijnp/pyx042

By:

Escobar, Angélica P.;
González, Marcela P.;
Meza, Rodrigo C.;
Noches, Verónica;
Henny, Pablo;
Gysling, Katia;
España, Rodrigo A.;
Fuentealba, José A.;
Andrés, María E.

Publication type:

Article

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 670, doi. 10.1093/ijnp/pyx032

By:

Solé, Brisa;
Jiménez, Esther;
Torrent, Carla;
Reinares, Maria;
del Mar Bonnin, Caterina;
Torres, Imma;
Varo, Cristina;
Grande, Iria;
Valls, Elia;
Salagre, Estela;
Sanchez-Moreno, Jose;
Martinez-Aran, Anabel;
Carvalho, André F.;
Vieta, Eduard

Publication type:

Article

Facilitation of Contextual Fear Extinction by Orexin-1 Receptor Antagonism Is Associated with the Activation of Specific Amygdala Cell Subpopulations.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 654, doi. 10.1093/ijnp/pyx029

By:

Flores, África;
Herry, Cyril;
Maldonado, Rafael;
Berrendero, Fernando

Publication type:

Article

Preclinical Evidence That 5-HT<sub>1B</sub> Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 644, doi. 10.1093/ijnp/pyx025

By:

Garcia, Raul;
Cotter, Austin R.;
Leslie, Kenneth;
Olive, M. Foster;
Neisewander, Janet L.

Publication type:

Article

Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI).

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 624, doi. 10.1093/ijnp/pyx040

By:

Savulich, George;
Piercy, Thomas;
Fox, Chris;
Suckling, John;
Rowe, James B.;
O'Brien, John T.;
Sahakian, Barbara J.

Publication type:

Article

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

Published in:

International Journal of Neuropsychopharmacology, 2017, v. 20, n. 8, p. 634, doi. 10.1093/ijnp/pyx026

By:

Hsiao-I Kuo;
Paulus, Walter;
Batsikadze, Giorgi;
Jamil, Asif;
Min-Fang Kuo;
Nitsche, Michael A.

Publication type:

Article